Form 4: Director E. Perot Bissell Increases Acadia Healthcare Stake

Sentiment:

Statement of Changes in Beneficial Ownership


Director E. Perot Bissell acquired 11,831 shares of Acadia Healthcare Company, Inc. through equity grants and a retainer election.

Summary

  • Director E. Perot Bissell acquired a total of 11,831 shares of Acadia Healthcare common stock on May 6, 2026.
  • 6,331 shares were acquired as an equity grant, which will vest over a 3-year period in equal annual installments starting May 6, 2027.
  • 5,500 shares were acquired as part of an election to receive the 2026 annual director cash retainer in common stock.
  • Following these transactions, Mr. Bissell's total beneficial ownership increased to 57,486 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it represents standard director compensation and alignment rather than a strategic shift or market-moving financial update.

Positives

  • Director demonstrates alignment with shareholders by electing to receive compensation in equity rather than cash.
  • Increased equity stake indicates confidence in the long-term prospects of the company.

Negatives

  • None identified.

Risks

  • Vesting schedule for the 6,331 granted shares spans three years, meaning full ownership is contingent upon continued service.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Management Comments

  • The transaction reflects Mr. Bissell's election to receive his annual cash retainer as a director for 2026 in shares of common stock.

Industry Context

StockSavvy.ai notes that director equity elections are standard corporate governance practices intended to align board member interests with those of long-term shareholders.

Comparison to Industry Standards

  • The practice of paying director retainers in equity is consistent with standard governance practices among S&P 500 and mid-cap healthcare companies to ensure board alignment.
  • The 3-year vesting schedule for equity grants is in line with typical market practices for non-employee director compensation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationElection to receive annual cash retainer in common stock.05/06/2026Increases director equity alignment with shareholders.

Stakeholder Impact

  • Shareholders: Positive signal regarding director commitment to the company.

Next Steps

  • Vesting of 6,331 shares beginning May 6, 2027.

Key Dates

DateDescription
05/06/2026Date of the reported equity transactions.
05/08/2026Date the Form 4 was filed with the SEC.
05/06/2027Beginning of the 3-year vesting period for the 6,331 granted shares.

Keywords

Acadia Healthcare, ACHC, Insider Trading, Form 4, Director Compensation, Equity Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.